PDK1 and osteosarcoma: Its critical role in regulating glycolysis and cell proliferation underscores the potential of PDK1 as both a prognostic biomarker and a candidate target.Future studies focusing on selective inhibition of PDK1 and its role in immune modulation could open new avenues for the treatment of osteosarcoma and other cancers driven by metabolic reprogramming.